These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21382695)

  • 1. Effects of quetiapine on executive functioning deficits in schizophrenia: short-term effect.
    Mendoza Quiñones R; Cabral Calderin Y; Garcia A; Caballero A; Domínguez M; Martín Reyes M
    Schizophr Res; 2011 Aug; 130(1-3):293-4. PubMed ID: 21382695
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive effects of six months of treatment with quetiapine in antipsychotic-naïve first-episode schizophrenia.
    Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
    Psychiatry Res; 2011 May; 187(1-2):49-54. PubMed ID: 21075453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of quetiapine treatment on facial emotion recognition deficits in schizophrenia patients.
    Cabral-Calderin Y; Mendoza-Quiñones R; Garcia A; Caballero A; Domínguez M; Reyes MM
    Schizophr Res; 2010 Jun; 119(1-3):275-6. PubMed ID: 20406719
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning.
    Harvey PD; Patterson TL; Potter LS; Zhong K; Brecher M
    Am J Psychiatry; 2006 Nov; 163(11):1918-25. PubMed ID: 17074943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cognition in schizophrenia research: from etiology to treatment.
    Goldberg TE; Gomar JJ
    Am J Psychiatry; 2009 Jun; 166(6):631-4. PubMed ID: 19487396
    [No Abstract]   [Full Text] [Related]  

  • 6. Quetiapine treatment and improved cognitive functioning in borderline personality disorder.
    Van den Eynde F; De Saedeleer S; Naudts K; Day J; Vogels C; van Heeringen C; Audenaert K
    Hum Psychopharmacol; 2009 Dec; 24(8):646-9. PubMed ID: 19946934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does cognitive function improve with quetiapine in comparison to haloperidol?
    Velligan DI; Newcomer J; Pultz J; Csernansky J; Hoff AL; Mahurin R; Miller AL
    Schizophr Res; 2002 Jan; 53(3):239-48. PubMed ID: 11738537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings.
    Velligan DI; Prihoda TJ; Sui D; Ritch JL; Maples N; Miller AL
    J Clin Psychiatry; 2003 May; 64(5):524-31. PubMed ID: 12755654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive efficacy of quetiapine in early-onset first-episode psychosis: a 12-week open label trial.
    Urben S; Baumann P; Barcellona S; Hafil M; Preuss U; Peter-Favre C; Clarke S; Halfon O; Holzer L
    Psychiatr Q; 2012 Sep; 83(3):311-24. PubMed ID: 22101738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of quetiapine in the treatment of panic attacks in patients with schizophrenia: 3 case reports.
    Takahashi H; Sugita T; Yoshida K; Higuchi H; Shimizu T
    J Neuropsychiatry Clin Neurosci; 2004; 16(1):113-5. PubMed ID: 14990767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building a neurocognitive profile of thought disorder in schizophrenia using a standardized test battery.
    Tan EJ; Rossell SL
    Schizophr Res; 2014 Jan; 152(1):242-5. PubMed ID: 24291545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis.
    Good KP; Kiss I; Buiteman C; Woodley H; Rui Q; Whitehorn D; Kopala L
    Br J Psychiatry Suppl; 2002 Sep; 43():s45-9. PubMed ID: 12271800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of Seroquel in schizophrenia].
    Chakhava VO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):63-4. PubMed ID: 11026140
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term remission of schizophrenia in an adolescent treated with quetiapine.
    Hayden F
    J Child Adolesc Psychopharmacol; 2001; 11(3):289-93. PubMed ID: 11642479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood dehydroepiandrosterone sulfate as a prognostic index of treatment efficacy in residual schizophrenia].
    Ivanova SA; Fedorenko OIu; Semke AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):49-51. PubMed ID: 21329014
    [No Abstract]   [Full Text] [Related]  

  • 17. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
    Meiron O; Hermesh H; Katz N; Weizman A
    Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin elevation with quetiapine.
    Alexiadis M; Whitehorn D; Woodley H; Kopala L
    Am J Psychiatry; 2002 Sep; 159(9):1608-9. PubMed ID: 12202292
    [No Abstract]   [Full Text] [Related]  

  • 19. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.
    Bosia M; Anselmetti S; Pirovano A; Ermoli E; Marino E; Bramanti P; Smeraldi E; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):81-5. PubMed ID: 19818823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.
    Velligan DI; Miller AL
    J Clin Psychiatry; 1999; 60 Suppl 23():25-8. PubMed ID: 10625197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.